Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Apremilast shows promise for several skin conditions but needs more research.

The combination treatment showed some improvement but wasn't significantly better than using betamethasone valerate alone.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.

Vitiligo patients have higher hydrogen peroxide levels and lower E-cadherin, affecting skin cell adhesion and pigmentation.

Segmental vitiligo affects hair follicle melanocytes, causing small, uniform depigmented spots.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Vitiligo patients often have nail problems, so checking their nails is important.

Oxidative stress is important in causing alopecia areata.

New treatments for skin conditions in children include a preferred drug for birthmark reduction, proactive creams for eczema and vitiligo, a safe psoriasis medication, and special tissues and socks for eczema and fungal infections.

Genetics, stress, and health issues can cause early hair greying, which affects self-esteem, and there's no cure, only hair dye.

JAK inhibitors show promise for treating various skin diseases.

Melatonin, the sleep hormone, can help treat skin conditions like dermatitis, hyperpigmentation, and scalp disorders, and may also aid in skin aging prevention and regeneration. However, it's not recommended for asthma due to its pro-inflammatory effect.

taVNS reduces vitiligo symptoms in mice.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

Dermatological conditions are complex and treatments often have mixed results.